Literature DB >> 11761014

Cerebral response to electric stimulation of the colon and abdominal skin in healthy subjects and patients with irritable bowel syndrome.

P Rössel1, P Pedersen, D Niddam, L Arendt-Nielsen, A C Chen, A M Drewes.   

Abstract

BACKGROUND: Visceral hyperalgesia may play an important part in the pathophysiology of the irritable bowel syndrome (IBS). We investigated the neuronal afferent pathways in healthy volunteers and IBS patients by recording evoked potentials (EPs) elicited by electrical stimulation of the colon and abdominal skin inside and outside the referred pain area.
METHODS: Six healthy subjects and nine IBS patients met the inclusion criteria. Morphology and topography of EPs to painful electrical stimuli were estimated in the rectosigmoid junction and on the skin inside/outside the referred pain areas.
RESULTS: The EPs to painful stimuli of the gut showed a shorter latency and a smaller amplitude of the first positive peak (P1) in the IBS group. The controls had a mid-latency frontal positive component after 100 ms, whereas no reliable early activation was seen in the IBS patients. In controls, a single late (>150 ms) positive component was seen, whereas the late component was biphasic in the IBS group. The EPs to painful stimuli of the two skin areas differed in IBS patients, but not in controls.
CONCLUSION: Differences in the EPs to electrical painful stimulation of the sigmoid colon and skin inside/outside the experimentally evoked referred pain area were seen comparing healthy subjects and IBS patients. The results indicate altered central nervous system responses.

Entities:  

Mesh:

Year:  2001        PMID: 11761014     DOI: 10.1080/003655201317097092

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

1.  Cortical and spinal evoked potential response to electrical stimulation in human rectum.

Authors:  Brian Garvin; Lisa Lovely; Alex Tsodikov; Danielle Minecan; Shaungson Hong; John W Wiley
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

2.  Comparison of electroacupuncture and moxibustion on brain-gut function in patients with diarrhea-predominant irritable bowel syndrome: A randomized controlled trial.

Authors:  Ji-meng Zhao; Jin-hua Lu; Xiao-jun Yin; Xing-kui Chen; Yue-hua Chen; Wei-jun Tang; Xiao-ming Jin; Lu-yi Wu; Chun-hui Bao; Huan-gan Wu; Yin Shi
Journal:  Chin J Integr Med       Date:  2015-04-06       Impact factor: 1.978

Review 3.  Functional findings in irritable bowel syndrome.

Authors:  Iris Posserud; Amanda Ersryd; Magnus Simrén
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

4.  Short latency cerebral response evoked by painful electrical stimulation applied to the human sigmoid colon and to the convergent referred somatic pain area.

Authors:  Petra Rössel; Lars Arendt-Nielsen; David Niddam; Andrew C N Chen; Asbjørn M Drewes
Journal:  Exp Brain Res       Date:  2003-04-24       Impact factor: 1.972

Review 5.  New technologies to investigate the brain-gut axis.

Authors:  Abhishek Sharma; Dina Lelic; Christina Brock; Peter Paine; Qasim Aziz
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

6.  Alteration of the spinal modulation of nociceptive processing in patients with irritable bowel syndrome.

Authors:  B Coffin; D Bouhassira; J-M Sabaté; L Barbe; R Jian
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 7.  Long-term potentiation in spinal nociceptive pathways as a novel target for pain therapy.

Authors:  Ruth Ruscheweyh; Oliver Wilder-Smith; Ruth Drdla; Xian-Guo Liu; Jürgen Sandkühler
Journal:  Mol Pain       Date:  2011-03-28       Impact factor: 3.395

8.  Comparison of the analgesic effects between electro-acupuncture and moxibustion with visceral hypersensitivity rats in irritable bowel syndrome.

Authors:  Ji-Meng Zhao; Liang Li; Liu Chen; Yin Shi; Yu-Wei Li; Hai-Xia Shang; Lu-Yi Wu; Zhi-Jun Weng; Chun-Hui Bao; Huan-Gan Wu
Journal:  World J Gastroenterol       Date:  2017-04-28       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.